(Q42286179)

English

Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial

scientific article published on 16 November 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1 reference

based on heuristic

inferred from title

Haemophilus influenzae

object named as

Haemophilus influenzae

1 reference

based on heuristic

inferred from title

12

object named as

Terhi M Kilpi

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Taneli Puumalainen

7

object named as

Taneli Puumalainen

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

author name string

Arto A Palmu

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Jukka Jokinen

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Dorota Borys

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Heta Nieminen

4

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Esa Ruokokoski

5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Lotta Siira

6

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Patricia Lommel

8

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Marjan Hezareh

9

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Marta Moreira

10

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Lode Schuerman

11

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

language of work or name

0 references

publication date

16 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

381

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

9862

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

214-222

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961854-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961854-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961854-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961854-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pneumococcal disease in South Australia: vaccine success but no time for complacency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961854-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Eradication of invasive pneumococcal disease due to the seven-valent pneumococcal conjugate vaccine serotypes in Calgary, Alberta.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961854-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961854-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961854-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961854-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity of a 2-dose priming and booster vaccination with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961854-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961854-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961854-6

7 January 2021

based on heuristic

inferred from DOI database lookup

From Quellung to multiplex PCR, and back when needed, in pneumococcal serotyping

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961854-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Simple sample size calculation for cluster-randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961854-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961854-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961854-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961854-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961854-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of Kawasaki disease in northern European countries.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961854-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961854-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Trends and geographical variation in invasive pneumococcal infections in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961854-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Trends in incidence of pneumococcal disease before introduction of conjugate vaccine: South West England, 1996-2005.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961854-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Invasive pneumococcal diseases in birth cohorts vaccinated with PCV-7 and/or PHiD-CV in the province of Quebec, Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961854-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(12)61854-6

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42286179&oldid=2100004838"